Clinical Trials Directory

Trials / Completed

CompletedNCT01783457

e-Learning & Development of an Evidence-based Psychoeducational Programme for First Episode Psychosis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
177 (actual)
Sponsor
Basque Health Service · Other Government
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

Treatment delay in psychosis usually lead to slower recovery, an increase in associated comorbidity and greater deterioration in social and family life of patients. Previous studies indicate that an early intervention with guidelines for increasing adherence to treatment, disease awareness and condition management leads to better progression of the disorder and is therefore related to a better prognosis. Several studies have found that the rate of relapse is higher in patients with pharmacological treatment alone compared to those also receiving psychoeducation, who tend to improve their adherence to treatment and reduce toxic drugs dosage. Hypotheses: * Individual psychoeducation will be effective as complementary therapy to pharmacological treatment in patients with a first psychotic episode, improving disease evolution. * BDNF levels will increase more in the patients receiving individual therapy compared to those without it. * Psychoeducation can be performed similarly in all participating centers if the therapists receive the same training and use the same psychoeducation material. * The use of telemedicine for the follow-up of the patients will help improve the welfare work and therefore the disease evolution.

Detailed description

Treatment delay in psychosis usually lead to slower recovery, an increase in associated comorbidity and greater deterioration in social and family life of patients. Previous studies indicate that an early intervention with guidelines for increasing adherence to treatment, disease awareness and condition management leads to better progression of the disorder and is therefore related to a better prognosis. Several studies have found that the rate of relapse is higher in patients with pharmacological treatment alone compared to those also receiving psychoeducation, who tend to improve their adherence to treatment and reduce toxic drugs dosage. Hypotheses: * Individual psychoeducation will be effective as complementary therapy to pharmacological treatment in patients with a first psychotic episode, improving the disease evolution. * BDNF levels will increase more in the patients receiving individual therapy compared to those without it. * Psychoeducation can be performed similarly in all participating centers if the therapists receive the same training and use the same psychoeducation material. * The use of telemedicine for the follow-up of the patients will help improve the welfare work and therefore the disease evolution. Primary Objective: * To assess the effectiveness of individual psychoeducation together with telemedicine (telephone assistance) as an adjuvant therapy in the pharmacological treatment of patients with first episode psychosis, regarding functionality of patients and positive and negative symptoms. Secondary Objectives: * To analyse certain biological parameters (BDNF and oxidative stress) in both arms (intervention and control) at baseline and during re-assessment (at six months and after completion of treatment). * To analyse the effectiveness of online training of psychotherapists who will provide psychoeducation to patients with first episode psychosis.

Conditions

Interventions

TypeNameDescription
OTHERControlUsual treatment: pharmacological treatment + regular sessions with their psychiatrist.
OTHERIndividual psychoeducationUsual treatment + individual psychoeducational programme, consisting of 14 sessions of 60 minutes every other week for six months, focused on improving patient awareness of their condition, adherence to treatment, identification of prodromes, early intervention in potential relapses, anxiety management techniques, social skills, healthy lifestyle habits and problem solving. Programme of sessions available upon request.

Timeline

Start date
2011-01-01
Primary completion
2015-06-01
Completion
2015-06-01
First posted
2013-02-05
Last updated
2016-01-26

Locations

6 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT01783457. Inclusion in this directory is not an endorsement.